Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NUS | Nu Skin Enterprises, Inc.

IndexRUT P/E16.51 EPS (ttm)1.41 Insider Own0.60% Shs Outstand49.93M Perf Week-3.04%
Market Cap1.16B Forward P/E8.78 EPS next Y2.65 Insider Trans-6.44% Shs Float49.30M Perf Month-1.36%
Income70.10M PEG2.42 EPS next Q0.64 Inst Own94.70% Short Float / Ratio2.68% / 1.65 Perf Quarter-27.50%
Sales2.04B P/S0.57 EPS this Y-27.60% Inst Trans-0.54% Short Interest1.32M Perf Half Y-39.39%
Book/sh17.93 P/B1.30 EPS next Y8.03% ROA3.80% Target Price31.50 Perf Year-37.03%
Cash/sh5.07 P/C4.60 EPS next 5Y6.81% ROE7.90% 52W Range22.63 - 45.55 Perf YTD-44.78%
Dividend1.56 P/FCF580.02 EPS past 5Y-8.50% ROI9.70% 52W High-48.89% Beta1.17
Dividend %6.70% Quick Ratio0.90 Sales past 5Y-0.50% Gross Margin71.10% 52W Low2.87% ATR0.62
Employees3800 Current Ratio1.80 Sales Q/Q-10.80% Oper. Margin3.20% RSI (14)38.24 Volatility2.34% 2.45%
OptionableYes Debt/Eq0.57 EPS Q/Q-20.20% Profit Margin3.40% Rel Volume0.54 Prev Close23.85
ShortableYes LT Debt/Eq0.41 EarningsAug 01 AMC Payout105.80% Avg Volume803.10K Price23.28
Recom3.00 SMA20-1.26% SMA50-9.56% SMA200-34.85% Volume434,256 Change-2.39%
Date Action Analyst Rating Change Price Target Change
Jan-31-23Downgrade Jefferies Buy → Hold $43 → $39
Feb-12-21Downgrade DA Davidson Buy → Neutral
Oct-02-20Upgrade BofA Securities Underperform → Neutral $54 → $58
Jul-02-20Upgrade Jefferies Hold → Buy $42 → $50
Jul-02-20Upgrade DA Davidson Neutral → Buy
Mar-09-20Downgrade Deutsche Bank Buy → Hold $40 → $28
Dec-05-19Resumed Citigroup Neutral
Nov-06-19Downgrade Citigroup Buy → Neutral
Oct-30-19Upgrade Stifel Sell → Hold $38.50 → $45
Jul-17-19Downgrade Jefferies Buy → Hold $40
Sep-21-23 11:55AM
Sep-06-23 10:26AM
Aug-31-23 11:31AM
Aug-29-23 11:24AM
10:08PM Loading…
Aug-09-23 10:08PM
Aug-05-23 08:04AM
Aug-02-23 11:39AM
Aug-01-23 05:55PM
Jul-27-23 04:05PM
09:05AM Loading…
Jul-26-23 11:07AM
Jul-18-23 10:32AM
Jul-14-23 09:40AM
Jul-10-23 04:10PM
Jul-08-23 08:32AM
Jun-25-23 11:26AM
Jun-21-23 08:00PM
Jun-09-23 06:23AM
Jun-07-23 12:05PM
Jun-02-23 11:31AM
May-23-23 01:16PM
May-07-23 08:07AM
May-04-23 10:37AM
06:50AM Loading…
May-03-23 06:25PM
May-02-23 11:29AM
May-01-23 10:55AM
Apr-27-23 09:40AM
Apr-26-23 08:00PM
Apr-19-23 04:05PM
Apr-18-23 09:17AM
Mar-30-23 04:20PM
Mar-17-23 03:02PM
Mar-15-23 08:20AM
Mar-07-23 08:34AM
Feb-19-23 07:07AM
Feb-17-23 06:56AM
Feb-16-23 10:06AM
Feb-15-23 06:55PM
Feb-14-23 06:36AM
Feb-13-23 10:27AM
Feb-08-23 10:00AM
Feb-06-23 07:36AM
Jan-11-23 09:30AM
Jan-10-23 12:52PM
Jan-09-23 04:05PM
Dec-31-22 04:30PM
Dec-25-22 07:58AM
Dec-23-22 04:13AM
Dec-12-22 10:15AM
Dec-08-22 01:32PM
Dec-02-22 11:31AM
Nov-29-22 02:25PM
Nov-28-22 06:53PM
Nov-22-22 01:40PM
Nov-18-22 05:30AM
Nov-17-22 01:10PM
Nov-16-22 03:47PM
Nov-09-22 05:45AM
Nov-07-22 03:08PM
Nov-06-22 07:03AM
Nov-03-22 10:08AM
Nov-02-22 06:45PM
Oct-31-22 12:53PM
Oct-26-22 10:01AM
Oct-07-22 10:13AM
Oct-06-22 07:30AM
Oct-04-22 04:05PM
Sep-21-22 04:05PM
Sep-12-22 09:09AM
Sep-09-22 03:57PM
Sep-06-22 10:37AM
Aug-24-22 10:23AM
Aug-21-22 08:11AM
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LIPMAN ANDREW DDirectorAug 25Sale23.332,00046,66056,625Aug 28 05:04 PM
Nathanson LauraDirectorAug 21Sale24.126,068146,36010,300Aug 22 05:33 PM
Battle Emma S.DirectorAug 07Sale26.151,27233,2637,619Aug 08 04:33 PM
LIPMAN ANDREW DDirectorJul 25Sale28.992,00057,98058,625Jul 25 06:08 PM
LIPMAN ANDREW DDirectorJun 26Sale32.122,00064,24060,625Jun 26 06:42 PM
LIPMAN ANDREW DDirectorMay 25Sale34.282,00068,56058,393May 26 04:50 PM
WOODBURY EDWINA DDirectorMay 09Sale37.871,25547,52715,469May 09 06:23 PM
LIPMAN ANDREW DDirectorApr 25Sale40.752,00081,50060,393Apr 25 05:25 PM
LIPMAN ANDREW DDirectorMar 27Sale39.292,00078,58062,393Mar 27 06:42 PM
Hatchett Steven KeithChief Product OfficerMar 09Option Exercise30.4521,155644,17079,523Mar 09 06:55 PM
Hatchett Steven KeithChief Product OfficerMar 09Sale39.7821,155841,54658,368Mar 09 06:55 PM
CHANG JOSEPH YChief Scientific OfficerMar 02Option Exercise30.4525,000761,35846,234Mar 03 06:32 PM
Lawrence Mark HChief Financial OfficerMar 02Option Exercise30.4518,041549,34883,290Mar 03 06:34 PM
Lawrence Mark HChief Financial OfficerMar 02Sale40.8026,1441,066,67557,146Mar 03 06:34 PM
CHANG JOSEPH YChief Scientific OfficerMar 02Sale40.7725,0001,019,25021,234Mar 03 06:32 PM
CHANG JOSEPH YChief Scientific OfficerMar 01Option Exercise30.6368,4852,097,69689,719Mar 03 06:32 PM
CHANG JOSEPH YChief Scientific OfficerMar 01Sale40.4468,4852,769,53321,234Mar 03 06:32 PM
NAPIERSKI RYAN SPresident and CEOFeb 28Option Exercise30.6310,000306,300178,784Feb 28 07:46 PM
NAPIERSKI RYAN SPresident and CEOFeb 28Sale40.4210,000404,154168,784Feb 28 07:46 PM
NAPIERSKI RYAN SPresident and CEOFeb 27Option Exercise30.6321,513658,943190,297Feb 28 07:46 PM
NAPIERSKI RYAN SPresident and CEOFeb 27Sale41.3821,513890,208168,784Feb 28 07:46 PM
Thomas James DChief Accounting OfficerFeb 23Sale41.122,829116,32817,928Feb 23 05:58 PM
LIPMAN ANDREW DDirectorFeb 22Sale41.421,00041,42064,393Feb 23 06:00 PM
Battle Emma S.DirectorFeb 22Sale41.7098741,1584,659Feb 23 06:06 PM
LIPMAN ANDREW DDirectorJan 23Sale42.271,00042,27065,393Jan 23 06:58 PM
LIPMAN ANDREW DDirectorDec 22Sale40.751,00040,75066,393Dec 22 05:50 PM
CHANG JOSEPH YChief Scientific OfficerDec 18Option Exercise37.586,800255,54429,757Dec 20 05:15 PM
NAPIERSKI RYAN SPresident and CEONov 25Option Exercise33.9725,000849,150147,683Nov 28 04:48 PM
NAPIERSKI RYAN SPresident and CEONov 25Sale38.4525,000961,250122,683Nov 28 04:48 PM
LIPMAN ANDREW DDirectorNov 22Sale38.161,00038,16067,393Nov 22 05:40 PM
LIPMAN ANDREW DDirectorOct 21Sale35.921,00035,92068,393Oct 24 05:25 PM